IN2012DN01285A - - Google Patents
Info
- Publication number
- IN2012DN01285A IN2012DN01285A IN1285DEN2012A IN2012DN01285A IN 2012DN01285 A IN2012DN01285 A IN 2012DN01285A IN 1285DEN2012 A IN1285DEN2012 A IN 1285DEN2012A IN 2012DN01285 A IN2012DN01285 A IN 2012DN01285A
- Authority
- IN
- India
- Prior art keywords
- nitrite
- nitrate
- subject
- compound
- angiogenesis
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 230000002491 angiogenic effect Effects 0.000 abstract 3
- 229910002651 NO3 Inorganic materials 0.000 abstract 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 2
- YBVAXJOZZAJCLA-UHFFFAOYSA-N nitric acid nitrous acid Chemical compound ON=O.O[N+]([O-])=O YBVAXJOZZAJCLA-UHFFFAOYSA-N 0.000 abstract 2
- 206010029113 Neovascularisation Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009168928 | 2009-07-17 | ||
| JP2010128057A JP5791064B2 (ja) | 2009-07-17 | 2010-06-03 | 医薬用組成物 |
| PCT/JP2010/061768 WO2011007755A1 (ja) | 2009-07-17 | 2010-07-12 | 血管新生制御組成物および血管新生制御方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01285A true IN2012DN01285A (https=) | 2015-05-15 |
Family
ID=43449363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1285DEN2012 IN2012DN01285A (https=) | 2009-07-17 | 2010-07-12 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20120114768A1 (https=) |
| EP (1) | EP2455091A4 (https=) |
| JP (1) | JP5791064B2 (https=) |
| CN (1) | CN102470146B (https=) |
| IN (1) | IN2012DN01285A (https=) |
| WO (1) | WO2011007755A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6284341B2 (ja) | 2012-10-24 | 2018-02-28 | 国立大学法人東京農工大学 | 未熟児網膜症の治療又は予防剤、未熟児網膜症の検査方法及び未熟児網膜症の治療又は予防物質のスクリーニング方法 |
| JP6042197B2 (ja) * | 2012-12-11 | 2016-12-14 | エア・ウォーター株式会社 | 肺障害治療剤 |
| JP6153838B2 (ja) * | 2013-10-04 | 2017-06-28 | エア・ウォーター株式会社 | 血管透過性抑制剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731294A (en) | 1993-07-27 | 1998-03-24 | Hybridon, Inc. | Inhibition of neovasularization using VEGF-specific oligonucleotides |
| CA2176934A1 (en) * | 1993-11-17 | 1995-05-26 | Ramnath Sasisekharan | Method for inhibiting angiogenesis using heparinase |
| JPH10273450A (ja) * | 1997-03-27 | 1998-10-13 | Toagosei Co Ltd | 眼内血管新生性疾患治療薬 |
| WO1998043621A1 (en) * | 1997-03-31 | 1998-10-08 | The Children's Medical Center Corporation | Nitrosylation to inactivate apoptotic enzymes |
| AU3109199A (en) * | 1998-03-25 | 1999-10-18 | Large Scale Biology Corporation | Benzoates derivatives for inhibiting angiogenesis |
| AU3609300A (en) * | 1999-03-01 | 2000-09-21 | Human Genome Sciences, Inc. | Human serpin proteins |
| AU779991B2 (en) * | 1999-08-10 | 2005-02-24 | Board Of Regents, The University Of Texas System | Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight |
| JP4210826B2 (ja) | 2001-01-19 | 2009-01-21 | 参天製薬株式会社 | ウレア誘導体を有効成分とする血管新生阻害剤 |
| US20070135380A1 (en) * | 2005-08-12 | 2007-06-14 | Radiorx, Inc. | O-nitro compounds, pharmaceutical compositions thereof and uses thereof |
| US20080069904A1 (en) * | 2006-07-18 | 2008-03-20 | Oronsky Bryan T | Inhibition of angiogenesis through nitric oxide tachyphylaxis |
| JP2008110950A (ja) | 2006-10-31 | 2008-05-15 | Japan Health Science Foundation | 糖尿病網膜症の治療方法 |
| CA2678097C (en) * | 2007-02-26 | 2023-03-14 | Jon Lundberg | New use of nitrites and nitrates and compositions containing these |
| ES2442720T3 (es) * | 2008-07-31 | 2014-02-13 | Nicox S.A. | Glucocorticoides unidos a ésteres de nitrato por medio de un enlazador aromático en posición 21 y su uso en oftalmología |
| US20100197702A1 (en) * | 2009-02-04 | 2010-08-05 | Hellberg Mark R | Ophthalmic composition with nitric oxide donor compound and method of forming and using same |
-
2010
- 2010-06-03 JP JP2010128057A patent/JP5791064B2/ja not_active Expired - Fee Related
- 2010-07-12 WO PCT/JP2010/061768 patent/WO2011007755A1/ja not_active Ceased
- 2010-07-12 IN IN1285DEN2012 patent/IN2012DN01285A/en unknown
- 2010-07-12 US US13/383,805 patent/US20120114768A1/en not_active Abandoned
- 2010-07-12 CN CN201080032449.6A patent/CN102470146B/zh not_active Expired - Fee Related
- 2010-07-12 EP EP20100799813 patent/EP2455091A4/en not_active Ceased
-
2013
- 2013-05-20 US US13/897,603 patent/US8974836B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20120114768A1 (en) | 2012-05-10 |
| JP5791064B2 (ja) | 2015-10-07 |
| WO2011007755A1 (ja) | 2011-01-20 |
| CN102470146B (zh) | 2014-09-10 |
| CN102470146A (zh) | 2012-05-23 |
| US20130251823A1 (en) | 2013-09-26 |
| EP2455091A4 (en) | 2012-12-19 |
| JP2011037830A (ja) | 2011-02-24 |
| EP2455091A1 (en) | 2012-05-23 |
| US8974836B2 (en) | 2015-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009129509A3 (en) | Methods and compositions for treating post-operative pain comprising a local anesthetic | |
| WO2009129437A3 (en) | Methods and compositions for treating post-operative pain comprising clonidine | |
| MY160894A (en) | Oligosaccharide composition for treating skin diseases | |
| BR112014015482A8 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
| WO2009106991A3 (en) | Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders | |
| MX2022004012A (es) | Solucion de bloqueo de cateter y terapia de bloqueo de cateter. | |
| MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
| NZ586302A (en) | Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising | |
| WO2011041478A8 (en) | Hematopoietic stem cells for use in the treatment of a kidney injury | |
| NZ599265A (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| RU2013132566A (ru) | Терапевтическое средство от грыжи межпозвоночного диска | |
| WO2009035534A3 (en) | Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif) | |
| SG10201807789WA (en) | Vaginal composition and use thereof | |
| WO2014165723A3 (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
| WO2006098603A3 (en) | Composition comprising isoorientin for suppressing histamine | |
| PH12015502465A1 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| IN2012DN01285A (https=) | ||
| WO2012106058A3 (en) | Animal treatments | |
| MX2018011539A (es) | Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas. | |
| PL2165704T3 (pl) | Zastosowanie alweryny w leczeniu dolegliwości skórnych | |
| MX2020007817A (es) | Prevención y tratamiento del trastorno del sueño. | |
| WO2009073184A8 (en) | Compositions for inducing labor and associated methods | |
| WO2009131850A3 (en) | Pai-1 expression and activity inhibitors for the treatment of ocular disorders | |
| MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
| Kimura et al. | Biophysical evaluation of fractional laser skin resurfacing with an Er: YSGG laser device in Japanese skin |